PABLO FRANCISCO BELAUNZARAN ZAMUDIO



DATOS GENERALES
Nombre completo   PABLO FRANCISCO BELAUNZARAN ZAMUDIO
Máximo nivel de estudios   ESPECIALIDAD
Antigüedad académica en la UNAM   1 año
NOMBRAMIENTOS
Último  TECNICO ACADEMICO ASOCIADO A MT No Definitivo
Facultad de Medicina
TECNICO ACADEMICO ASOCIADO A MT No Definitivo
Facultad de Medicina
Desde 01-01-2016 hasta 31-08-2017
ESTIMULOS, PROGRAMAS, PREMIOS Y RECONOCIMIENTOS
* SNI II2019 - 2022
* SNI I2016 - 2018

INFORMACIÓN DE PUBLICACIONES
Firmas  
Belaunzaran P. Belaunzarán-Zamudio P.F. Belaunzaran-Zamudio, Pablo Belaunzaran-Zamudio, Pablo F. Francisco Belaunzaran-Zamudio, Pablo
ID's SCOPUS  
35085712600
ORCID's  
0000-0003-4775-4734
Áreas de conocimiento  
Biochemistry and molecular biology Clinical neurology Gerontology Immunology Infectious diseases
Medicine, general and internal Multidisciplinary sciences Pharmacology and pharmacy Psychology, clinical Public, environmental and occupational health
Tropical medicine Veterinary sciences Virology Agricultural and biological sciences (miscellaneous) Clinical psychology
Dermatology Epidemiology Genetics Health policy Immunology and allergy
Infectious diseases Medicine (miscellaneous) Multidisciplinary Neurology (clinical) Oncology
Pharmacology Pharmacology, toxicology and pharmaceutics (miscellaneous) Physics and astronomy (miscellaneous) Psychiatry and mental health Public health, environmental and occupational health
Veterinary (miscellaneous)
Coautorías con entidades de la UNAM  
  • Facultad de Medicina
Revistas en las que ha publicado  (32):
  1. AIDS RESEARCH AND HUMAN RETROVIRUSES, Estados Unidos America (2016, 2017, 2018, 2023)
  2. AM J EPIDEMIOL, Estados Unidos America (2020)
  3. ANNALS OF INTERNAL MEDICINE, Estados Unidos America (2022)
  4. ANTIVIRAL RESEARCH, Países Bajos (2019)
  5. BMC INFECTIOUS DISEASES, Reino Unido (2020, 2021, 2022)
  6. BULLETIN OF THE WORLD HEALTH ORGANIZATION, Suiza (2015)
  7. CLINICAL INFECTIOUS DISEASES, Estados Unidos America (2017)
  8. CONTEMPORARY CLINICAL TRIALS, Estados Unidos America (2024)
  9. EBioMedicine, Países Bajos (2016)
  10. EPIDEMIOLOGY AND INFECTION, Estados Unidos America (2018)
  11. FRONTIERS IN IMMUNOLOGY, Suiza (2017, 2022)
  12. FRONTIERS IN NEUROLOGY, Suiza (2021)
  13. HIV MEDICINE, Reino Unido (2019, 2021)
  14. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, Estados Unidos America (2018)
  15. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, Reino Unido (2020)
  16. INTERNATIONAL JOURNAL OF STD & AIDS, Reino Unido (2018)
  17. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, Reino Unido (2019, 2020, 2021)
  18. Journal Of Virus Eradication, (2017)
  19. LANCET HIV, Reino Unido (2014, 2019, 2021)
  20. LANCET REGIONAL HEALTH-AMERICAS, Países Bajos (2022)
  21. MEDICAL MYCOLOGY, Reino Unido (2019)
  22. MOLECULAR MEDICINE, Estados Unidos America (2022)
  23. NATURE COMMUNICATIONS, Reino Unido (2019)
  24. Open Forum Infectious Diseases, Estados Unidos America (2015, 2018, 2020)
  25. Pathogens And Immunity, (2017)
  26. PLOS NEGLECTED TROPICAL DISEASES, Estados Unidos America (2021)
  27. PLOS ONE, Estados Unidos America (2017, 2018, 2020, 2022)
  28. PSYCHOTHERAPY RESEARCH, Estados Unidos America (2024)
  29. Public Health, Reino Unido (2022)
  30. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, Reino Unido (2019)
  31. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, México (2015, 2022)
  32. Skin Appendage Disorders, Suiza (2022)


Descargar PDF

Documentos indexados (WoS y Scopus)

# Título del documento Autores Año Revista Fuente Citas WoS Citas Scopus
1Development and content validity of EVAD: A novel tool for evaluating and classifying the severity of adverse events for psychotherapeutic clinical trialsCoautor: Belaunzarán-Zamudio P.F., Mejía-Castrejón J., Sierra-Madero J.G., Fresan-Orellana A., et al.2024PSYCHOTHERAPY RESEARCHWoS-id: 001044560100001
Scopus-id: 2-s2.0-85166950952
00
2Preventable sources of bias in subgroup analyses and secondary outcomes of randomized trials2ᵒ autor y autor de correspondencia: Belaunzarán-Zamudio P.F., Núñez I.2024CONTEMPORARY CLINICAL TRIALSWoS-id: 001286526300001
Scopus-id: 2-s2.0-85200249263
11
3Incomplete Antiretroviral Therapy Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV Infection in Mexico1ᵉʳ autor: Belaunzaran-Zamudio, Pablo F., Naranjo, Lizbeth, Caro-Vega, Yanink, Castillo-Mancilla, Jose R., et al.2023AIDS RESEARCH AND HUMAN RETROVIRUSESWoS-id: 000936658100001
Scopus-id: 2-s2.0-85150000405
22
4Result Turnaround Time of RT-PCR for SARS-CoV-2 is the Main Cause of COVID-19 Diagnostic Delay: A Country-Wide Observational Study of Mexico and Colombia2ᵒ autor: Belaunzarán-Zamudio P.F., Núñez I., Caro-Vega Y.2022REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATIONWoS-id: 000751326000001
Scopus-id: 2-s2.0-85128160140
910
5Incidence of Cytomegalovirus disease and viral replication kinetics in seropositive liver transplant recipients managed under preemptive therapy in a tertiary-care center in Mexico City: a retrospective cohort studyCoautor: Belaunzarán-Zamudio P.F., Fernández-García O.A., García-Juárez I., Vilatoba M., et al.2022BMC INFECTIOUS DISEASESWoS-id: 000755126200002
Scopus-id: 2-s2.0-85124797948
43
6Diagnostic precision of local and World Health Organization definitions of symptomatic COVID-19 cases: an analysis of Mexico's capitalCoautor y autor de correspondencia: Belaunzarán-Zamudio P.F., Núñez I., Caro-Vega Y.2022Public HealthWoS-id: 000784028900029
Scopus-id: 2-s2.0-85126528318
55
7Seroepidemiology of SARS-CoV-2 in healthcare personnel working at the largest tertiary COVID-19 referral hospitals in Mexico CityCoautor: Belaunzarán-Zamudio P.F., Dávila-Conn V., Soto-Nava M., Caro-Vega Y.N., et al.2022PLOS ONEWoS-id: 000784193600035
Scopus-id: 2-s2.0-85126685344
45
8Nail changes in people living with human immunodeficiency virus: Observational and cross-sectional study in a third-level hospitalCoautor: Belaunzarán-Zamudio P.F., Flores-Bozo L.R., Méndez-Flores S., Olvera-Rodríguez V., et al.2022Skin Appendage DisordersWoS-id: 000808539500001
Scopus-id: 2-s2.0-85129768668
11
9Relationship Between Anemia and Systemic Inflammation in People Living With HIV and Tuberculosis: A Sub-Analysis of the CADIRIS Clinical TrialCoautor: Belaunzaran-Zamudio P.F., Araújo-Pereira M., Barreto-Duarte B., Arriaga M.B., et al.2022FRONTIERS IN IMMUNOLOGYWoS-id: 000821850100001
Scopus-id: 2-s2.0-85133844334
57
10Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trialCoautor: Belaunzaran-Zamudio, Pablo F., Fragoso-Saavedra, Sergio, Núñez I., Audelo-Cruz, Belem M., et al.2022MOLECULAR MEDICINEWoS-id: 000880335300002
Scopus-id: 2-s2.0-85141555280
77
11Clinical effects of durability of immunosuppression in virologically suppressed ART-initiating persons with HIV in Latin America. A retrospective cohort studyCoautor: Belaunzarán-Zamudio P.F., Caro-Vega Y., Rebeiro P.F., Shepherd B.E., et al.2022LANCET REGIONAL HEALTH-AMERICASWoS-id: 000904623700012
Scopus-id: 2-s2.0-85126975031
12
12Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity An Observational StudyCoautor: Belaunzaran P., Romo M.L., Patel R.C., Edwards J.K., et al.2022ANNALS OF INTERNAL MEDICINEScopus-id: 2-s2.0-85123814148
018
13The effect of protease inhibitor-based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART-naïve patients with HIV-infectionCoautor: Belaunzaran-Zamudio P.F., Figueroa M.I., Camiro-Zuñiga A., Sierra Madero J., et al.2021HIV MEDICINEWoS-id: 000599516900001
Scopus-id: 2-s2.0-85097664776
22
14Antiretroviral therapy and Kaposi's sarcoma trends and outcomes among adults with HIV in Latin AmericaCoautor: Belaunzaran-Zamudio P.F., Castilho J.L., Kim A., Jenkins C.A., et al.2021JOURNAL OF THE INTERNATIONAL AIDS SOCIETYWoS-id: 000617060500003
Scopus-id: 2-s2.0-85100280898
76
15Comparison of clinical characteristics of zika and dengue symptomatic infections and other acute illnesses of unidentified origin in Mexico1ᵉʳ autor: Belaunzarán-Zamudio P.F., Mateja A., Guerra-De-blas P.C., Rincón-León H.A., et al.2021PLOS NEGLECTED TROPICAL DISEASESWoS-id: 000620636800004
Scopus-id: 2-s2.0-85102395176
76
16Comparison of the Impact of Zika and Dengue Virus Infection, and Other Acute Illnesses of Unidentified Origin on Cognitive Functions in a Prospective Cohort in Chiapas Mexico1ᵉʳ autor: Belaunzarán-Zamudio P.F., Ortega-Villa A.M., Mimenza-Alvarado A.J., Guerra-De-Blas P.D.C., et al.2021FRONTIERS IN NEUROLOGYWoS-id: 000636663400001
Scopus-id: 2-s2.0-85103613834
56
17Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort studyCoautor: Belaunzaran-Zamudio P.F., Smiley C.L., Rebeiro P.F., Cesar C., et al.2021LANCET HIVWoS-id: 000645001400009
Scopus-id: 2-s2.0-85105894823
3537
18Different epidemiological profiles in patients with Zika and dengue infection in Tapachula, Chiapas in Mexico (2016?2018): an observational, prospective cohort studyCoautor: Belaunzarán-Zamudio P.F., Rincón León H.A., Caballero Sosa S., Ruiz E., et al.2021BMC INFECTIOUS DISEASESWoS-id: 000690903900003
Scopus-id: 2-s2.0-85114019614
22
19The HIV epidemic in Latin America: a time to reflect on the history of success and the challenges ahead2ᵒ autor: Belaunzarán-Zamudio P.F., Crabtree-Ramírez B., Cortes C.P., Morales M., et al.2020JOURNAL OF THE INTERNATIONAL AIDS SOCIETYWoS-id: 000522447100013
Scopus-id: 2-s2.0-85080839419
2225
20Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America1ᵉʳ autor: Belaunzaran-Zamudio P.F., Caro-Vega Y., Giganti M.J., Castilho J.L., et al.2020PLOS ONEWoS-id: 000542759600043
Scopus-id: 2-s2.0-85086691765
1718
21The population impact of late presentation with advanced HIV disease and delayed antiretroviral therapy in adults receiving HIV care in Latin America1ᵉʳ autor: Belaunzarán-Zamudio P.F., Caro-Vega Y.N., Shepherd B.E., Rebeiro P.F., et al.2020AM J EPIDEMIOLWoS-id: 000569363500012
Scopus-id: 2-s2.0-85082794485
3133
22Myocardial inflammatory changes before and after antiretroviral therapy initiation in people with advanced human immunodeficiency virus diseaseCoautor: Belaunzaran-Zamudio P.F., Piñeirua-Menéndez A., Flores-Miranda R., Sánchez-Nava D., et al.2020Open Forum Infectious DiseasesWoS-id: 000577171000034
Scopus-id: 2-s2.0-85092090822
23
23A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocolCoautor: Belaunzaran-Zamudio, Pablo F., Fragoso-Saavedra, Sergio, Iruegas-Nunez, David A., Quintero-Villegas, Alejandro, et al.2020BMC INFECTIOUS DISEASESWoS-id: 000582746200005
Scopus-id: 2-s2.0-85092768750
911
24Patterns of signs, symptoms, and laboratory values associated with Zika, dengue, and undefined acute illnesses in a dengue endemic region: Secondary analysis of a prospective cohort study in southern MexicoCoautor: Belaunzarán-Zamudio P.F., Hunsberger S., Ortega-Villa A.M., Powers J.H., et al.2020INTERNATIONAL JOURNAL OF INFECTIOUS DISEASESScopus-id: 2-s2.0-85089221780
010
25Mexico's fragmented health system as a barrier to HIV care2ᵒ autor: Belaunzaran-Zamudio P.F., Sierra-Madero J.G., Crabtree-Ramírez B., Magis-Rodriguez C.2019LANCET HIVWoS-id: 000457727600006
Scopus-id: 2-s2.0-85060961011
1213
26An immunocompromised patient & multiorgan cystic echinococcosisCoautor: Belaunzaran-Zamudio P.F., Lopez Luis B.A., Valdivia-Cayoja A.R., Soto-Ramírez L.E.2019QJM-AN INTERNATIONAL JOURNAL OF MEDICINEWoS-id: 000462590800010
Scopus-id: 2-s2.0-85062504880
12
27Immediate treatment of acute HIV in a tertiary healthcare center: bridging gaps in communication using smartphonesCoautor: Belaunzarán-Zamudio P.F., Perez-Patrigeon S., Camiro-Zúñiga A., Jaramillo-Jante M.R., et al.2019HIV MEDICINEWoS-id: 000464948800003
Scopus-id: 2-s2.0-85063645559
22
28Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcomeCoautor: Belaunzarán-Zamudio P.F., Ravichandran S., Hahn M., Ramos-Castañeda J., et al.2019NATURE COMMUNICATIONSWoS-id: 000465837900003
Scopus-id: 2-s2.0-85064956193
4247
29Serial real-time RT-PCR and serology measurements substantially improve Zika and Dengue virus infection classification in a co-circulation areaCoautor: Belaunzarán-Zamudio P.F., Gouel-Cheron A., Lumbard K., Hunsberger S., et al.2019ANTIVIRAL RESEARCHWoS-id: 000499939700012
Scopus-id: 2-s2.0-85074984732
1113
30Temporal changes in ART initiation in adults with high CD4 counts in Latin America: a cohort studyCoautor: Belaunzarán-Zamudio P.F., Crabtree-Ramírez B.E., Caro-Vega Y., Shepherd B.E., et al.2019JOURNAL OF THE INTERNATIONAL AIDS SOCIETYWoS-id: 000505786500012
Scopus-id: 2-s2.0-85077014848
44
31Progressive disseminated histoplasmosis in Latin America and the Caribbean in people receiving highly active antiretroviral therapy for HIV infection: A systematic reviewCoautor: Belaunzarán-Zamudio P.F., Cano-Torres J.O., Olmedo-Reneaum A., Esquivel-Sánchez J.M., et al.2019MEDICAL MYCOLOGYWoS-id: 000509362500001
Scopus-id: 2-s2.0-85068832857
1112
32Evaluating the care cascade after antiretroviral therapy initiation in Latin AmericaCoautor: Belaunzaran-Zamudio, Pablo, Wolff, Marcelo J., Cortes, Claudia P., Mejia, Fernando A., et al.2018INTERNATIONAL JOURNAL OF STD & AIDSWoS-id: 000418610600001
Scopus-id: 2-s2.0-85042463178
1011
33Is substance use associated with HIV cascade outcomes in Latin America?Coautor: Belaunzarán-Zamudio P.F., De Boni R.B., Peratikos M.B., Shepherd B.E., et al.2018PLOS ONEWoS-id: 000427473500058
Scopus-id: 2-s2.0-85044070394
1415
34Durability of efavirenz compared with boosted protease inhibitor-based regimens in antiretroviral-naïve patients in the Caribbean and central and South America2ᵒ autor: Belaunzarán-Zamudio P.F., Caro-Vega Y., Crabtree-Ramírez B.E., Shepherd B.E., et al.2018Open Forum Infectious DiseasesWoS-id: 000429449800001
Scopus-id: 2-s2.0-85043402295
67
35Association between Frailty and HIV-Associated Neurodegenerative Disorders among Older Adults Living with HIV2ᵒ autor: Belaunzarán-Zamudio P.F., Zamudio-Rodríguez A., Sierra-Madero J.G., Cuellar-Rodríguez J., et al.2018AIDS RESEARCH AND HUMAN RETROVIRUSESWoS-id: 000431182400008
Scopus-id: 2-s2.0-85046690418
2829
36Trends in proportion of older HIV-infected people in care in Latin America and the Caribbean: A growing challenge2ᵒ autor: Belaunzarán-Zamudio P.F., Caro-Vega Y., Crabtree-Ramírez B., Shepherd B.E., et al.2018EPIDEMIOLOGY AND INFECTIONWoS-id: 000439936400016
Scopus-id: 2-s2.0-85047875295
1110
37Correlates of depressive symptoms among older adults living with HIVCoautor: Belaunzarán-Zamudio P.F., Avila-Funes J.A., Zamudio-Rodríguez A., Muñoz-Nevárez L.A., et al.2018INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYWoS-id: 000449080200011
Scopus-id: 2-s2.0-85051293721
44
38Risk factors associated with prolonged hospital length-of-stay: 18-year retrospective study of hospitalizations in a tertiary healthcare center in Mexico2ᵒ autor: Belaunzarán-Zamudio P.F., Marfil-Garza B.A., Gulias-Herrero A., Zuñiga A.C., et al.2018PLOS ONEWoS-id: 000449512300090
Scopus-id: 2-s2.0-85056395067
4857
39Correction: Risk factors associated with prolonged hospital length-of-stay: 18-year retrospective study of hospitalizations in a tertiary healthcare center in Mexico (PLoS ONE (2018) 13: 11(e0207203) Doi : 10.1371/journal.pone.0207203)2ᵒ autor: Belaunzarán-Zamudio P.F., Marfil-Garza B.A., Gulias-Herrero A., Zuñiga A.C., et al.2018PLOS ONEWoS-id: 000454149400083
Scopus-id: 2-s2.0-85058917122
01
40Burden of HIV, Syphilis, and Hepatitis B and C Among Inmates in a Prison State System in Mexico1ᵉʳ autor: Belaunzaran-Zamudio, Pablo F., Mosqueda-Gomez, Juan L., Macias-Hernandez, Alejando, Rodriguez-Ramirez, Sonia, et al.2017AIDS RESEARCH AND HUMAN RETROVIRUSESWoS-id: 000402996700003
Scopus-id: 2-s2.0-85020387884
1926
41Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico1ᵉʳ autor: Belaunzaran-Zamudio, Pablo F., Mosqueda-Gomez, Juan L., Macias-Hernandez, Alejando, Sierra-Madero, Juan G., et al.2017PLOS ONEWoS-id: 000404541500039
Scopus-id: 2-s2.0-85021382214
2122
42Country of residence is associated with distinct inflammatory biomarker signatures in HIV-infected patientsCoautor: Belaunzaran-Zamudio, Pablo F., Manion, Maura, Andrade, Bruno B., DerSimonian, Rebecca, et al.2017Journal Of Virus EradicationWoS-id: 000409108800003
120
43Add-on Pyridostigmine enhances CD4+ T-cell recovery in HIV-1-infected immunological non-responders: A proof-of-concept studyCoautor: Belaunzarán-Zamudio P.F., Valdés-Ferrer S.I., Crispín J.C., Rodríguez-Osorio C.A., et al.2017FRONTIERS IN IMMUNOLOGYWoS-id: 000413096600001
Scopus-id: 2-s2.0-85031719421
1315
44Comparison of kaposi sarcoma risk in human immunodeficiency virus-positive adults across 5 continents: A multiregional multicohort studyCoautor: Belaunzaran P., Rohner E., Bütikofer L., Schmidlin K., et al.2017CLINICAL INFECTIOUS DISEASESScopus-id: 2-s2.0-85032789580
045
45Immunologic effects of maraviroc in hiv-infected patients with severe cd4 lymphopenia starting antiretroviral therapy: A sub-study of the cadiris trial1ᵉʳ autor: Belaunzarán-Zamudio P.F., Azzoni L., Canaday D.H., Caro-Vega Y.N., et al.2017Pathogens And ImmunityScopus-id: 2-s2.0-85066139725
03
46Correlates of Prevalent Disability Among HIV-Infected Elderly Patients2ᵒ autor: Francisco Belaunzaran-Zamudio, Pablo, Alberto Avila-Funes, Jose, Tamez-Rivera, Oscar, Crabtree-Ramirez, Brenda, et al.2016AIDS RESEARCH AND HUMAN RETROVIRUSESWoS-id: 000369760500008
Scopus-id: 2-s2.0-84958959593
1617
47Vitamin D, D-dimer, Interferon gamma, and sCD14 Levels are Independently Associated with Immune Reconstitution Inflammatory Syndrome: A Prospective, International StudyCoautor: Belaunzaran-Zamudio, Pablo F., Musselwhite, Laura W., Andrade, Bruno B., Ellenberg, Susan S., et al.2016EBioMedicineWoS-id: 000370806400022
Scopus-id: 2-s2.0-84954348274
3234
48Monitoring of HIV treatment in seven countries in the WHO region of the Americas1ᵉʳ autor: Belaunzarán-Zamudio P.F., Caro-Vega Y.N., Shepherd B.E., Crabtree-Ramírez B.E., et al.2015BULLETIN OF THE WORLD HEALTH ORGANIZATIONWoS-id: 000359966400010
Scopus-id: 2-s2.0-84938538216
1619
49CD4 response up to 5 years after combination antiretroviral therapy in human immunodeficiency virus-infected patients in Latin America and the Caribbean2ᵒ autor: Belaunzarán-Zamudio P.F., Luz P.M., Crabtree-Ramírez B., Caro-Vega Y., et al.2015Open Forum Infectious DiseasesWoS-id: 000365786200030
Scopus-id: 2-s2.0-84978328152
77
50Surveillance of Oseltamivir-Resistant Influenza A(H1N1)pdm09 in Guanajuato State, Mexico from 2009 to 20122ᵒ autor: Belaunzarán-Zamudio P.F., Mosqueda-Gómez J.L., Barba A., Córdova-Villalobos J.A., et al.2015REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATIONWoS-id: 000368650700004
Scopus-id: 2-s2.0-85040636133
11
51Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): A double-blind, randomised, placebo-controlled trialCoautor: Belaunzarán-Zamudio P.F., Sierra-Madero J.G., Ellenberg S.S., Rassool M.S., et al.2014LANCET HIVWoS-id: 000363789800007
Scopus-id: 2-s2.0-84921985871
4550
Descargar PDF

Documentos no indexados (Humanindex)

# Título del documento ISSN Revista Año Fuente
Descargar PDF

No se encuentran registros en la base de datos de capítulos de libros (WoS y Scopus).

Descargar PDF

Obras con ISBN (Indautor)

# Título del documento Autores Alcance Año ISBN Fuente
1Perspectivas Multidimensionales Del VihBelaunzarán Zamudio, Pablo Francisco, Torres Cruz, César, Caro Vega, Yanink Neried, Libro Completo20209786072818941INDAUTOR
Descargar PDF

Proyectos

# Nombre Participantes Convocatoria Fecha Inicio Fecha Fin
1067 2015 Condicones de vida que influyen en las personas que no continúan con la atención con una prueba rápida reactiava de VIH caso: Clínica Especializada CondesaPABLO FRANCISCO BELAUNZARAN ZAMUDIO,
Ingresos Propios02-06-201502-06-2018
2Estudio de prevalencia de tuberculosis latente en personas con VIH atendidas en los servicios de salud especializados en VIH y sida de la Ciudad de México.PABLO FRANCISCO BELAUNZARAN ZAMUDIO,
Ingresos Propios01-12-201501-12-2020
Descargar PDF

Participación en Comités de Tesis

# Título del documento Tipo de Tesis Sinodales Autores Año Entidad Url
1Evaluación de metas de control de diabetes en pacientes con VIHTesis de EspecialidadPABLO FRANCISCO BELAUNZARAN ZAMUDIO; ALFONSO GULIAS HERRERO; JULIO CESAR HERNANDEZ JIMENEZ; Álvarez Morales, Rigoberto Doroteo; 2018Escuela Nacional Colegio de Ciencias y Humanidades "Sur", Facultad de Medicina,
2Deterioro neurocognitivo asociado a VIH en pacientes atendidos en el INCMNSZ, respuesta clínica a largo plazo posterior al inicio de terapia antirretroviral altamente activaTesis de EspecialidadPABLO FRANCISCO BELAUNZARAN ZAMUDIO; Ramírez González, Luis Esteban; 2015
3Marcadores pronósticos de recuperación inmune en una cohorte de pacientes con VIH avanzadoTesis de EspecialidadPABLO FRANCISCO BELAUNZARAN ZAMUDIO; YANINK NERIED CARO VEGA; López Martínez, Alondra; 2013
Descargar PDF

Docencia Impartida

# Entidad Nivel Asignatura Año Semestre Alumnos
1Facultad de MedicinaDoctoradoESTANCIA SOCIOMÉDICA20212022-11
2Facultad de MedicinaDoctoradoTUTORÍA VII20212022-11
Descargar PDF

No se encuentran registros en la base de datos de patentes.

Descargar PDF

No se encuentran registros en la base de datos de libros completos (Humanindex).

Descargar PDF

Capítulos de libros (Humanindex)

# Título del libro Título del capítulo ISBN Editorial Año Fuente